Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Biogen Inc. BIIB: Among the Cheap Pharmaceutical Stocks to Buy According to Analysts

February 25, 2025
According to analysts at Yahoo Finance, Biogen Inc. (BIIB) is one of the cheap pharmaceutical stocks to buy. The company has been gaining attention in the market due to its diverse portfolio and potential for growth. Biogen's stock is evolving into a strong value play, making it an attractive investment option. With its promising pipeline of innovative drugs, the company is poised for long-term success. For accurate predictions on the movement of Biogen's stock, it is recommended to seek professional advice from Stocks Prognosis.

Find out how the BIOGEN INC. rate is expected to change

Get Forecast for BIIB

Investor opinions & comments:

I've been keeping an eye on Biogen, and it's exciting to see their stock evolving into a strong value play
— from DanielTaylor at 02-27-2025 19:21
Biogen's promising pipeline of innovative drugs sets them up for long-term success. I'm definitely considering buying their stocks
— from WyattRiley at 02-26-2025 14:19
This is great news for Biogen! Their diverse portfolio and potential for growth make them an attractive investment option
— from FinanceFlo at 02-26-2025 13:57
If you want to leave a comment, then you need Login or Register





Other news for BIIB

BIIBJune 11, 2025Biogen Inc. Presents Exciting Advances at Goldman Sachs Conference  ~1 min.

Biogen Inc. recently presented at the Goldman Sachs 46th Annual Global Healthcare Conference, showcasing their latest innovations in the healthcare sector....

BIIBApril 7, 2025Biogen Inc. Stock Hits Price Target Forecast on QuantWave, Generating 13.05% Profit  ~1 min.

In a recent development on QuantWave, the stock of Biogen Inc. has successfully reached the price target forecast, resulting in a profitable outcome for users....

BIIBApril 6, 2025Biogen Inc. Continues to Struggle with Declining Earnings and Investor Returns  ~2 min.

Biogen Inc., a leading biotechnology company, has reported a significant decrease in company earnings, losing a staggering US$697 million....

BIIBApril 4, 2025Biogen Inc. Stock Hits QuantWave Forecast Target with 11.12% Profit  ~2 min.

Biogen Inc. stock recently achieved the price target forecast set by QuantWave, signaling a successful prediction for investors....

BIIBApril 4, 2025Biogen Inc. Hits Price Target Forecast on QuantWave with 12.72% Profit  ~1 min.

Biogen Inc. has successfully reached the price target forecast set by QuantWave, resulting in a profit of 12.72%. The forecast signal was issued on March 21, 2025, when the stock was priced at 140.9 $....



Related news

VRTXJanuary 12, 2025Vertex Pharmaceuticals Incorporated Faces Setbacks in Clinical Trials  ~1 min.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares experienced a slide recently due to setbacks in its clinical trials....

REGNJanuary 2, 2025Regeneron Pharmaceuticals Continues to Impress Investors with Strong Returns  ~1 min.

In the past five years, Regeneron Pharmaceuticals (NASDAQ:REGN) has delivered a solid return of 89%, making it a favorable choice for investors....

REGNFebruary 10, 2025Regeneron Pharmaceuticals Inc REGN Q4 2024 Earnings Call Highlights: Strong Revenue Growth ... Yahoo Finance  ~1 min.

Regeneron Pharmaceuticals Inc. (REGN) recently held its Q4 2024 earnings call, highlighting strong revenue growth and positive developments in its portfolio....

REGNMarch 16, 2025JIM CRAMER ENCOURAGES INVESTORS TO OWN REGENERON PHARMACEUTICALS INC.  ~2 min.

In the latest episode of Mad Money, renowned financial expert Jim Cramer expressed his bullish stance on Regeneron Pharmaceuticals Inc. (REGN)....

VRTXMarch 22, 2025Vertex Pharmaceuticals VRTX: One of the Best Biotech Stocks to Buy According to Billionaires  ~2 min.

Vertex Pharmaceuticals Incorporated (VRTX) has been recognized as one of the top biotech stocks to invest in by billionaires....